News - Merck & Co, Noxafil


Current filters:

Merck & CoNoxafil

Popular Filters

Breakthrough status for Pfizer's palbociclib; Merck & Co Noxafil NDA accepted


Global pharma behemoth Pfizer (NYSE: PFE) is the latest to gain a "Breakthrough Therapy" designation…

Antibiotics and Infectious diseasesMerck & CoNorth AmericaNoxafilOncologypalbociclibPfizerPharmaceuticalRegulation

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top